Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501. Case and Commentary Nov 2019 How Should Surgeons Balance Transplantation Innovation With Acceptance of a Trauma Survivor’s Appearance? Carly Parnitzke Smith, PhD Counseling a patient about reconstructive surgery for a traumatic and disfiguring injury requires special consideration. AMA J Ethics. 2019;21(11):E953-959. doi: 10.1001/amajethics.2019.953. Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367. Case and Commentary Feb 2007 Ethics of Cutting-Edge Device Research Harvey L. Gordon, MD Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental. Virtual Mentor. 2007;9(2):86-90. doi: 10.1001/virtualmentor.2007.9.2.ccas1-0702. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Case and Commentary Jan 2005 Mrs. Douglas's Choice of Treatment for Her Husband, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005;7(1):35-42. doi: 10.1001/virtualmentor.2005.7.1.ccas7c-0501.
Case and Commentary Nov 2019 How Should Surgeons Balance Transplantation Innovation With Acceptance of a Trauma Survivor’s Appearance? Carly Parnitzke Smith, PhD Counseling a patient about reconstructive surgery for a traumatic and disfiguring injury requires special consideration. AMA J Ethics. 2019;21(11):E953-959. doi: 10.1001/amajethics.2019.953.
Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.
Case and Commentary Feb 2007 Ethics of Cutting-Edge Device Research Harvey L. Gordon, MD Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental. Virtual Mentor. 2007;9(2):86-90. doi: 10.1001/virtualmentor.2007.9.2.ccas1-0702.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.